KIT Inhibitor

Home/Tag: KIT Inhibitor

MSKCC Opens New Immunotherapy Trial for GIST

A new clinical trial combining targeted therapy with immunotherapy has just opened at Memorial Sloan-Kettering Cancer Center (MSKCC). This trial is the culmination of extensive pre-clinical investigations by MSKCC researchers. Although treatment with Gleevec [...]

By |2018-07-06T15:26:20-04:00August 1st, 2012|Clinical Trials, News|
Go to Top